Celldex Therapeutics
CLDX
CLDX
76 hedge funds and large institutions have $365M invested in Celldex Therapeutics in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
69% more funds holding
Funds holding: 45 → 76 (+31)
54.61% more ownership
Funds ownership: 22.58% → 77.19% (+55%)
20% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 10
Holders
76
Holding in Top 10
5
Calls
$13.2M
Puts
$4.61M
Top Buyers
| 1 | +$12.1M | |
| 2 | +$11.6M | |
| 3 | +$8.86M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$8.86M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$7.76M |
Top Sellers
| 1 | -$993K | |
| 2 | -$313K | |
| 3 | -$174K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$85.5K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$83K |